Pulmonary Hypertension

diagnosis of lung cancer :: Article Creator What Causes Lung Cancer? Scientists Are Working To Connect The Dots. For Sharon Fisher, the lung cancer diagnosis came as a gut punch. A simple cold had turned into a lingering feeling of congestion, with a dry cough. Eventually diagnosed with pneumonia, a closer look revealed a lesion in the left lobe of her lung. But, how? After all, she'd never been a smoker, was an avid hiker, was still the same weight she'd been since high school, had no history of illnesses, and was a foodie who ate no processed foods and cooked healthy meals for herself, in spite of her hectic work schedule. What most people do not realize is that in approximately 15% of lung cancer diagnoses, the patient has never smoked. And, they had no exposure to known carcinogens. While this fact has baffled the medical community, further exploration revealed that there were many more female never-smokers (as they are r...

tricuspid valve and pulmonary valve :: Article Creator 'Big Step Forward' For Transcatheter Tricuspid Valve Replacement: TRISCEND II SAN FRANCISCO, CA—Patients with severe tricuspid regurgitation (TR) treated with transcatheter valve replacement experienced a significant improvement in TR grade and had "meaningful" improvements in functional status and symptoms, according to data from the first 150 patients in the TRISCEND II study. These results were heralded as a big win for transcatheter tricuspid valve replacement given the good safety profile and near complete elimination of TR. Lead investigator Susheel Kodali, MD (NewYork-Presbyterian/Columbia University Irving Medical Center, New York, NY), said the results are welcomed because patients with severe, symptomatic TR don't have a lot of options.   "The ones that tend to go for surgery are younger and healthier," Kodali told TCTMD. "The majority of patien...

pah scleroderma :: Article Creator Scleroderma Directory What Is Artificial Skin? Experts continue to work on artificial skin options that can protect and detect things just like human skin. Learn more here. What to Know About Different Types of Ticks Several types of ticks exist in the U.S. Ticks are tiny arachnids that can cause diseases. Learn more about the types of ticks and the diseases they carry. What to Know About Smiley Piercings Find out what you need to know about smiley piercing placement, jewelry, risks, and more. Elastin: What to Know Find out what you need to know about elastin. Discover the pros, cons, risks, benefits, and how it may affect your health. What Is FUPA? Learn about FUPA and problems related to fatty upper pubic areas. Discover the symptoms and the best treatments for these weight-related issues. What Are Treatments for Keloid Scars? Keloid scars are thick irregular-looking scars. Learn abo...

double pulmonary embolism :: Article Creator Pulmonary Embolism During COVID Infection A Deadly Mix HONOLULU -- During the first year of the pandemic, patients with pulmonary embolism (PE) had higher in-hospital mortality rates when they also had concomitant COVID-19, according to a nationwide retrospective cohort study. Using data from the 2020 National Inpatient Sample Database (NIS), 19.8% of patients with both PE and COVID died in the hospital compared with 7.1% of those with PE but without COVID (adjusted OR 3.16, 95% CI 3.07-3.25, P<0.001), reported Rana Prathap Padappayil, MBBS, of Upstate Medical University in Syracuse, New York, during the CHEST annual meeting hosted by the American College of Chest Physicians. Patients with PE who had COVID were also more likely to require vasopressors (5.31% vs 2.66%; aOR 1.16, 95% CI 1.11-1.22) and extracorporeal membrane oxygenation (0.76% vs 0.30%; aOR 1.62, 95% CI 1.41-1.86), and had longer...

pulmonary high blood pressure :: Article Creator Pulmonary Arterial Hypertension Market Is Estimated To Be US$ 12.2 Billion By 2032 And Is Anticipated To Register A CAGR Of 5.5%. – By PMI Increased clinical trials for the development of therapies to treat pulmonary arterial hypertension and the availability of generic medications at reasonable prices as a result of increasing patent expiration are driving the growth of the pulmonary arterial hypertension market, with the oral segment expected to lead the market for PAH between 2022 and 2032. Covina, Oct. 18, 2023 (GLOBE NEWSWIRE) -- How is PAH diagnosed? Pulmonary Arterial Hypertension (PAH) is the form of broader condition called as pulmonary hypertension, where the increased pressure in vessels are caused by obstruction in small arteries of lungs. They are caused by high blood pressure in lungs arteries due to connective tissue disease, congenital heart disease and others. Rapidly increase...